Aberrant diffuse expression of p63 in adenocarcinoma of the prostate on needle biopsy and radical prostatectomy: report of 21 cases.
about
The pathology of unusual subtypes of prostate cancerComputer-aided detection of prostate cancer on tissue sectionsA-methylacyl-CoA racemase (AMACR) and prostate-cancer risk: a meta-analysis of 4,385 participants.Prostate adenocarcinomas aberrantly expressing p63 are molecularly distinct from usual-type prostatic adenocarcinomas.Aberrant cytoplasmic expression of p63 and prostate cancer mortality.T-cadherin in prostate cancer: relationship with cancer progression, differentiation and drug resistanceHOXB13 G84E-related familial prostate cancers: a clinical, histologic, and molecular surveyTumour markers in prostate cancer II: diagnostic and prognostic cellular biomarkers.Diagnosis of limited adenocarcinoma of the prostate.Diagnostic and prognostic molecular biomarkers for prostate cancer.Diagnostic utility of p63/P501S double sequential immunohistochemical staining in differentiating urothelial carcinoma from prostate carcinoma.Histopathology of Prostate Cancer.Comprehensive mutational analysis and mRNA isoform quantification of TP63 in normal and neoplastic human prostate cellsA case of prostatic adenocarcinoma with aberrant p63 expression: presentation with detailed immunohistochemical study and FISH analysis.Comparison of p40 (ΔNp63) and p63 expression in prostate tissues--which one is the superior diagnostic marker for basal cells?Different Growth Patterns of Canine Prostatic Carcinoma Suggests Different Models of Tumor-Initiating Cells.Retained basal cells in metastatic prostate cancer.Markers of clinical utility in the differential diagnosis and prognosis of prostate cancer.Prostate cancer: diagnostic criteria and role of immunohistochemistry.MAGI-2 Is a Sensitive and Specific Marker of Prostatic Adenocarcinoma: A Comparison With AMACR.Plasmacytoid-Type Cellular Differentiation in Polymorphous Low-Grade Adenocarcinoma.Antibody EPR3864 is specific for ERG genomic fusions in prostate cancer: implications for pathological practice.Immunohistochemical panel to characterize canine prostate carcinomas according to aberrant p63 expression.
P2860
Q26752906-FAE91C1D-B74F-4307-A173-F577F3D61D00Q33718744-0C694B09-962A-4752-BB82-51ED02C412EEQ35018146-C77752E9-D217-4DD6-B781-5CF50B82F174Q35132292-C583066F-1BB5-4154-AD05-03B7672FEF39Q37216001-B3A43385-699D-4366-AE91-BE0AC274C09FQ37601733-09621089-C70C-4602-B0A8-FCB0B27B3AC3Q37705596-A561FA68-7C8F-4977-B09A-DDCE81BA1DAAQ37878470-7BEE2316-5D28-44A4-B015-778F6AC97377Q37972698-360FAB97-C615-4734-9AB2-A6D67CC247E8Q37972703-F16BA603-8983-4906-9A14-FCBC383ED82DQ38269382-5CEFD680-B2D8-4693-B57E-8B305D14E2B2Q39227648-9D8B7F98-DAF9-4FD6-8234-F2542BF2C5D5Q39895605-3209A020-DCEC-47F2-A711-EAA616D2FB99Q39946539-C62103D4-656C-496E-ACEA-FAC1A89EF79AQ42438388-AE82C772-7695-4E27-9C3F-F87A9890B61BQ42473959-B7E30115-DB1D-4BBA-BA45-47DF815BD655Q42487260-550ABAA5-DA80-4B7E-9FB7-58D19C9A103BQ47215343-EBB0B1F2-EE20-49BA-9229-D1411098B14FQ49347844-A7C15776-E582-4818-B050-0F0B94879BBBQ51560512-E4C536C1-8EFC-4BE1-86FC-DA47180F617DQ53165311-08EBDC00-6352-4A63-9AAF-61371E15B12FQ54377548-8210E90F-FF08-433D-9D55-DC45AD11479EQ55470950-B1D2E1F9-F972-4720-B3BC-420C558596BD
P2860
Aberrant diffuse expression of p63 in adenocarcinoma of the prostate on needle biopsy and radical prostatectomy: report of 21 cases.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Aberrant diffuse expression of ...... tatectomy: report of 21 cases.
@en
Aberrant diffuse expression of ...... tatectomy: report of 21 cases.
@nl
type
label
Aberrant diffuse expression of ...... tatectomy: report of 21 cases.
@en
Aberrant diffuse expression of ...... tatectomy: report of 21 cases.
@nl
prefLabel
Aberrant diffuse expression of ...... tatectomy: report of 21 cases.
@en
Aberrant diffuse expression of ...... tatectomy: report of 21 cases.
@nl
P2093
P1476
Aberrant diffuse expression of ...... tatectomy: report of 21 cases.
@en
P2093
Adeboye O Osunkoya
Donna E Hansel
George J Netto
Jonathan I Epstein
Xinlai Sun
P304
P356
10.1097/PAS.0B013E318157020E
P407
P577
2008-03-01T00:00:00Z